FDA Inspection 1116566 — ULTRAtab Laboratories, Inc.

ULTRAtab Laboratories, Inc. — FEI 3003068822

The FDA completed an inspection of ULTRAtab Laboratories, Inc. on January 31, 2020 in Highland, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 31, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Highland, NY (United States)

Citations

IDCFRDescription
103321 CFR 211.22(a)Authority lacking to review records, investigate errors
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
126321 CFR 211.68(b)Computer control of master formula records
127021 CFR 211.68(b)input/output verification
189021 CFR 211.165(e)Test methods
363221 CFR 211.170(b)Annual visual exams of drug products